Jefferies Group’s Apyx Medical APYX Stock Holding History

Jefferies Group’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-12,100	Closed	-$76K	–	2499
2019 Q1	$76K	Buy	+12,100	New	+$93.6K	﹤0.01%	2159

Other funds holding APYX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Jefferies Group's APYX Position: Q2 2019 in Review

Jefferies Group sold out of Apyx Medical (APYX) in Q2 2019, closing a stake of 12,100 shares — an estimated $76K sold.

Jefferies Group first reported a position in APYX in Q1 2019 and held it in 1 quarter. The position peaked at $76K in Q1 2019. 66 funds tracked by Wall St. Rank hold APYX as of Q2 2019.

Jefferies Group reported no remaining Apyx Medical position as of Q2 2019 after selling out during the quarter.
Jefferies Group sold 12,100 Apyx Medical shares in Q2 2019, an estimated $76K.
Jefferies Group first reported a position in Apyx Medical in Q1 2019 and held it in 1 quarter.
Jefferies Group's Apyx Medical position peaked at $76K in Q1 2019.
66 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2019.

Based on Jefferies Group's 13F filing for Q2 2019, filed 14 Aug 2019.